fenclonine has been researched along with Cerebrovascular Disorders in 1 studies
Fenclonine: A selective and irreversible inhibitor of tryptophan hydroxylase, a rate-limiting enzyme in the biosynthesis of serotonin (5-HYDROXYTRYPTAMINE). Fenclonine acts pharmacologically to deplete endogenous levels of serotonin.
Cerebrovascular Disorders: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mrsulja, BB | 1 |
| Mrsulja, BJ | 1 |
| Spatz, M | 1 |
| Klatzo, I | 1 |
1 other study available for fenclonine and Cerebrovascular Disorders
| Article | Year |
|---|---|
Brain serotonin after experimental vascular occlusion.
Topics: Animals; Cerebral Cortex; Cerebrovascular Disorders; Fenclonine; Gerbillinae; Hydroxyindoleacetic Ac | 1976 |